Table 2.
Clinical indicators of the participants in this study (n = 30).
| Indicators | Total (n = 30) | MP-undetected (n = 6) | MP-detected (n = 24) | p value |
|---|---|---|---|---|
| SBP (mmHg) [mean, SD] | 128.5 ± 21.0 | 126.5 ± 26.1 | 129.0 ± 20.2 | 0.803 |
| DBP (mmHg) [mean, SD] | 80.5 ± 16.3 | 78.8 ± 24.0 | 80.9 ± 14.4 | 0.845 |
| Glucose (mmol/L) [median, IQR] | 7.6 (6.0, 10.1) | 7.4 (6.0, 9.5) | 8.2 (5.8, 10.9) | 0.860 |
| TC (mmol/L) [mean, SD] | 4.2 ± 1.1 | 4.2 ± 0.8 | 4.2 ± 1.1 | 0.966 |
| LDL (mmol/L) [mean, SD] | 2.5 ± 0.8 | 2.6 ± 0.7 | 2.5 ± 0.8 | 0.651 |
| HDL (mmol/L) [median, IQR] | 0.9 (0.8, 1.1) | 0.9 (0.8, 0.9) | 0.9 (0.8, 1.1) | 0.561 |
| TG (mmol/L) [median, IQR] | 1.1 (0.9, 1.8) | 1.5 (1.0, 1.9) | 1.1 (0.9, 1.6) | 0.347 |
| Lp(a) (mmol/L) [median, IQR] | 130.0 (53.2, 276.3) | 121.2 (73.9, 554.6) | 130.0 (47.3, 244.6) | 0.595 |
| Hcy (μmol/L) [median, IQR] | 9.9 (7.5, 12.0) | 11.1 (7.5, 16.6) | 9.7 (7.0, 11.4) | 0.296 |
| Platelets (109/L) [median, IQR] | 225.0 (190.8, 299.5) | 274.0 (203.8, 451.0) | 224.5 (190.0, 288.3) | 0.230 |
| PT (sec) [median, IQR] | 11.5 (10.8, 12.2) | 11.3 (10.7, 11.9) | 11.5 (10.7, 12.7) | 0.494 |
| TT (sec) [median, IQR] | 18.0 (17.6, 18.8) | 17.7 (17.6, 18.2) | 18.2 (17.6, 19.2) | 0.210 |
| APTT (sec) [median, IQR] | 27.3 (25.5, 28.3) | 27.9 (27.3, 30.0) | 26.7 (25.2, 27.9) | 0.093 |
| Fibrinogen (g/L) [mean, SD] | 3.7 ± 1.1 | 4.2 ± 0.9 | 3.6 ± 1.2 | 0.209 |
| D-dimer (μg/L) [mean, SD] | 7.9 ± 1.5 | 6.6 ± 0.5 | 8.3 ± 1.5 | <0.001 |
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglyceride; Lp(a), lipoprotein(a); Hcy, homocysteine; PT, prothrombin time; TT, thrombin time; APTT, activated partial thromboplastin time; MD, mean difference.